Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog



804 Features
More Help To Get Young People Talking

18 Dec 08

A £12 million action plan to improve services for children and young people with speech, language and communication needs was launched today by Health Secretary Alan Johnson and Children's Secretary Ed Balls.

New Universal Name Identities an ultra-modern-cyber-age-branding-platform offers exclusive global rights to name brands

16 Dec 08

Naseem Javed, widely recognized as global authority on global corporate nomenclature, image and cyber-branding, author of Naming for Power. Naseem is on global name identity projects and lecturing at various conferences on these ICANN issues.
Naseem Javed


15 Dec 08

- Dossier admits UK biotech at breaking point.
- Sector can still flourish – but needs major investment.
- Industry calls for new investment partnership with government.
- Creation of two new investment super funds critical to future success.

Ramsay Smith - Media House

Put People Power Into Action To Improve The NHS, Say Phil Hope And Ara Darzi

05 Dec 08

Patients are being urged to put people power into action from today by rating the service they receive in hospitals using a new tool on the NHS website.

Big Pharma squares up to changes

03 Dec 08

Paul Hartigan reports from the Financial Times Pharmaceutical Conference: London December 2nd and 3rd 2008
Paul Hartigan

ERBI Medtech Awards - news of the winners

02 Dec 08

Awards for Innovation, Export Achievement and NHS Partnership held at ERBI's Winter Ball at The Imperial War Museum, Duxford on November 29th 2008.
Aviva Grisby - Holdsworth Associates

Still No Progress: Mixed Sex Wards And Racial Inequalities

28 Nov 08

According to recent information from MIND, the leading mental health charity, Patient research released today by the Healthcare Commission has revealed that a shocking 68% of mental health inpatients are still being housed on mixed sex wards, showing no improvement on last year's figures

The real reason why GPs are hard to reach...

26 Nov 08

Our eMarketing team at PharmiWeb Solutions often works with pharma brand teams to find new ways to reach healthcare professionals with news of the latest product or initiative. And sometimes, it can be challenging, with all of the pressures and time constraints that the average primary care practice faces.

Re-emerging infectious diseases

24 Nov 08

We are facing a world where microbes once again have the potential to cause untreatable diseases, due to the resistance to virtually all available drugs. WHO suggests that even if the pharmaceutical industry were to step up the efforts to develop new drugs immediately, some diseases might still not have any effective therapies within the next ten years.

The Global Pain Market, 2008-2023

17 Nov 08

The global pain market generated total sales of $34bn in 2007 – but what will the figures be in the next 5 and 10 years? This report tells you. The pain market has marked strengths and advantages, but is also limited by problems and concerns.
Suvitha Damodaran - Visiongain - Ltd

Combating counterfeit drugs

14 Nov 08

White paper from CERAM highlights novel techniques to expose fake medicines and unlicensed manufacturing processes
Mandy Rymill - CERAM

The Global Anti-Addiction Market, 2008-2023

14 Nov 08

The global addiction market is significantly undervalued. The world’s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents?
Suvitha Damodaran - Visiongain Ltd

World Gastrointestinal Disorders

10 Nov 08

The gastrointestinal (GI) disorders market has been one of the largest and most profitable therapeutic areas in the world pharmaceutical industry. With a reported $49.9bn in revenues in 2007, the GI disorders market competes consistently with cardiovascular diseases and oncology for the top 3 therapeutic areas in terms of market value.
Suvitha Damodaran - Visiongain

Women’s Reproductive Disorders Therapeutics Report, 2008-2018

04 Nov 08

There is great potential for the women’s reproductive disorders therapeutics market – can you maximise your company’s potential in this growing market?
Andres Arias - Visiongain

Uncovering The Silent Suffering Of Millions of Women - dealing with Stress Incontinence

04 Nov 08

NHS Direct estimate that one in five UK women over forty years of age suffer from stress incontinence and, whilst it is often caused by childbirth or menopause, it can affect any women at any age.
Sian Rees

Dyselxia Awareness Week

03 Nov 08

Recent reports state that between four and five percent of the population suffer from Dyslexia. It is estimated that there are about 375,000 pupils in the UK with dyslexia and a total of some two million people who are severely affected. Yet it still can be difficult for parents to find the right help for their children.

Postmenopausal Osteoporotic Patients Granted Treatment Options by the National Institute for Health and Clinical Excellence (NICE)

31 Oct 08

Procter & Gamble Pharmaceuticals (P&GP) acknowledges the publication of the new Technology Appraisal Guidance (TAG 160, for the primary prevention, and 161 for the secondary prevention, of osteoporotic fragility fractures in post-menopausal women) issued by NICE.
Sebastian Stokes -Red Door Communications

ABPI Media Briefing Top Ups

29 Oct 08

The following is taken from the ABPI's Press Release dated 29th October 2008
ABPI press office

Global survey shows how perceptions of healthcare professionals and patients influence treatment of bipolar disorder

24 Oct 08

Global survey shows how perceptions of healthcare professionals and patients influence treatment of bipolar disorder
Olwen Glynn Owen - Pharmiweb Field Reporter

NHS Meets Key Commitments On Waiting And Progress On Tackling Infections

24 Oct 08

NHS staff (in England) are making excellent progress against two key priority areas - to reduce waiting times to 18 weeks and cut Clostridium difficile (C. difficile) infections - statistics released today show.

Boehringer Ingelheim and the search for new targeted cancer treatments

21 Oct 08

Boehringer Ingelheim and the search for new targeted cancer treatments
Kelly Smith - OgilvyHealthPR

Pharma Sales - A view from India

20 Oct 08

The ever-evolving healthcare industry has very few constants, and the pharmaceutical sales industry is just another piece of the puzzle that is in the middle of a major transformation. For multinationals, eager to sell their drugs in different countries, juggling between scores of different languages and different laws has always proved to be a major dampener.
A. Nair

World Stroke Day - Striking CT Images Illustrate Effect Of Stroke On The Brain

19 Oct 08

This week, organizations around the globe are working to create awareness and educate people about the signs, symptoms, treatment and prevention of one of the leading causes of death and disability––stroke. Wednesday, 29 October officially marks World Stroke Day.
Alex Young

King of Viagra is sentenced to 3 years imprisonment for supplying counterfeit medicines

15 Oct 08

Dr George Patino (aka Giorgio Giovanni Paticciano), 48 years old and a Mexican citizen by birth, was sentenced today at Kingston Crown Court to 3 years imprisonment.
MHRA Newsroom

Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share

15 Oct 08

Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
Lilly Newroom

New Data Shows Abbott's Bioabsorbable Drug Eluting Stent Is Absorbed Within Two Years - Leaving Behind Functioning Blood Vessels

15 Oct 08

Data Indicate Bioabsorbable Stent Platform Has Potential to Become the Next Major Breakthrough in Interventional Treatment
Abbott Newsroom

Johnson & Johnson Reports 2008 Third-Quarter Results

15 Oct 08

Sales of $15.9 Billion Increased 6.4% Versus a Year Ago; EPS was $1.17 Excluding 2007 Special Items, 2008 Third-Quarter EPS Increased 10.4%*
Johnson & Johnson Newsroom

Cardiovascular safety of vildagliptin, sitagliptin and others in the new DPP-4 inhibitor class of antidiabetic agents

13 Oct 08

The new oral antidiabetic drugs sitagliptin and vildagliptin work by boosting the guts incretin hormones GLP-1 and GIP to regulate insulin secretion following food intake and glucagon secretion when blood sugar is low.
Olwen Glynn Owen-Pharmiweb Field Reporter

Rheumatoid arthritis: treatment should consider patients' perspective

08 Oct 08

Current treatments for rheumatoid arthritis (RA) are failing to control patients' pain adequately, and health care professionals are not fully addressing patients' concerns, new research suggests. At the recent Annual Congress of Rheumatology meeting (EULAR) in Paris this summer, findings of a study presented during a UCB-sponsored symposium highlighted a mismatch between perceptions of patients and professionals as to what constitutes effective management of RA
Olwen Glynn Owen - Pharmiweb Field Reporter

MammaPrint testing pinpoints risk of breast cancer recurrence from the primary tumour`s genetic make-up

30 Sep 08

Deciding whether or not women with breast cancer require adjuvant chemotherapy after removal of the primary tumour has traditionally been based on a series of prognostic clinical features such as tumour size, lymph node involvement, and other factors. If risk of recurrence is deemed low, adjuvant therapy and its associated toxicity can be avoided. Molecular technology is now available to help clinicians decide on the risks of a particular tumour recurring, based on its genetic fingerprint.
Olwen Glynn Owen - Pharmiweb Field reporter

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.